Procter & Gamble Company (PG)
Cash conversion cycle
Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Days of inventory on hand (DOH) | days | 66.07 | 62.43 | 65.24 | 62.69 | 62.83 | 62.65 | 61.24 | 60.38 | 63.59 | 64.20 | 64.97 | 59.95 | 62.99 | 61.29 | 60.06 | 58.85 | 60.42 | 60.31 | 58.40 | 56.93 |
Days of sales outstanding (DSO) | days | 26.70 | 26.98 | 27.47 | 26.57 | 26.59 | 27.54 | 27.24 | 24.35 | 24.66 | 26.22 | 25.95 | 23.41 | 25.27 | 24.42 | 26.79 | 22.66 | 23.70 | 23.78 | 25.40 | 21.49 |
Number of days of payables | days | 129.57 | 128.91 | 137.43 | 137.29 | 121.55 | 124.70 | 124.22 | 124.61 | 117.19 | 120.50 | 127.08 | 128.85 | 125.74 | 129.99 | 135.44 | 134.95 | 122.15 | 121.76 | 122.13 | 124.99 |
Cash conversion cycle | days | -36.80 | -39.50 | -44.72 | -48.02 | -32.13 | -34.51 | -35.73 | -39.88 | -28.94 | -30.07 | -36.16 | -45.49 | -37.48 | -44.29 | -48.59 | -53.45 | -38.03 | -37.68 | -38.33 | -46.57 |
March 31, 2025 calculation
Cash conversion cycle = DOH + DSO – Number of days of payables
= 66.07 + 26.70 – 129.57
= -36.80
The Procter & Gamble Company's cash conversion cycle (CCC) has predominantly remained negative over the analyzed period from June 30, 2020, to March 31, 2025. A negative CCC indicates that the company is able to convert its investments in inventory and accounts receivable into cash more quickly than it pays its suppliers, thereby generating a cash inflow before settling its payables.
Throughout this period, the CCC has fluctuated within a range approximately from -53.45 days to -28.94 days. Notably, the cycle was most negative around June 30, 2021, at -53.45 days, suggesting an increased efficiency or a strategic stance that allowed the company to realize cash flows earlier relative to its payables. Conversely, the least negative points occurred around March 31, 2022, at -28.94 days, indicating a slight reduction in the cash conversion advantage.
In the subsequent years, the CCC demonstrated periods of slight improvements and setbacks, but overall, it maintained a largely negative trend, implying ongoing efficient cash management. The fluctuations do not show any sustained deterioration; rather, they reflect typical operational variations. For example, at the end of 2023, the CCC was recorded at -34.51 days, and in the latest quarter reported (March 31, 2025), it was at -36.80 days, indicating a relatively stable and efficient working capital cycle.
In summary, the data underscores that Procter & Gamble has consistently maintained a negative cash conversion cycle, which is favorable from a liquidity and working capital management standpoint. It suggests effective inventory and receivables management combined with strong supplier terms, enabling the company to sustain a cash inflow ahead of its payment obligations.
See also:
Procter & Gamble Company Cash Conversion Cycle (Quarterly Data)